Brief: Waverley Pharma Appoints Larry Thiessen As New President & CEO, Effective Feb. 1, 2020
Feb 3 (Reuters) - Waverley Pharma Inc WAVE.V :
* WAVERLEY PHARMA ANNOUNCES APPOINTMENT OF NEW PRESIDENT AND
CEO
* WAVERLEY PHARMA INC - NAMED LARRY THIESSEN AS NEW
PRESIDENT AND
CHIEF EXECUTIVE OFFICER, EFFECTIVE FEBRUARY 1, 2020
Source text for Eikon: ID:nCNWNmDpGa
Further company coverage: WAVE.V
(Reuters.Briefs@thomsonreuters.com)
Recent news on Waverley Pharma
See all newsBrief: Waverley Pharma Announces Chief Financial Officer Change
Brief: Waverley Pharma Acquires Us Based Pharmacy
Brief: Waverley Pharma Business Update
Brief: Waverley Pharma Provides Update On Its Parp-1 Inhibitor Program
Brief: Waverley Pharma - Co's Unit Awarded Exclusive Distribution Rights For Two Strengths Of Pemetrexed By NHS England